Pages that link to "Q35210772"
Jump to navigation
Jump to search
The following pages link to Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis (Q35210772):
Displaying 50 items.
- Peutz-Jeghers LKB1 mutants fail to activate GSK-3beta, preventing it from inhibiting Wnt signaling (Q24296680) (← links)
- Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma (Q24304196) (← links)
- High-level inducible Smad4-reexpression in the cervical cancer cell line C4-II is associated with a gene expression profile that predicts a preferential role of Smad4 in extracellular matrix composition (Q24683692) (← links)
- Pathways for aberrant angiogenesis in pancreatic cancer (Q24800215) (← links)
- Genetic alterations in pancreatic carcinoma (Q24801465) (← links)
- Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer (Q24801511) (← links)
- Surfing the p53 network (Q28032484) (← links)
- Role of TGFβ in regulation of the tumor microenvironment and drug delivery (review) (Q28081170) (← links)
- TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis (Q28083107) (← links)
- Targeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: molecular basis for therapeutic implications (Q28269990) (← links)
- The myc-miR-17~92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors (Q28295428) (← links)
- TGF-beta signaling in tumor suppression and cancer progression (Q29615427) (← links)
- Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses (Q30476201) (← links)
- High-throughput drug screening of the DPC4 tumor-suppressor pathway in human pancreatic cancer cells. (Q30988504) (← links)
- Divergent mechanisms underlie Smad4-mediated positive regulation of the three genes encoding the basement membrane component laminin-332 (laminin-5). (Q33355827) (← links)
- Secretion of MCP-1 and other paracrine factors in a novel tumor-bone coculture model (Q33405455) (← links)
- SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells (Q33556577) (← links)
- Pancreatic cancer: pathobiology, treatment options, and drug delivery (Q33749460) (← links)
- PRH/Hhex controls cell survival through coordinate transcriptional regulation of vascular endothelial growth factor signaling. (Q33826204) (← links)
- Loss of smad4 in Sertoli and Leydig cells leads to testicular dysgenesis and hemorrhagic tumor formation in mice (Q33826266) (← links)
- Biological approaches to therapy of pancreatic cancer (Q33899938) (← links)
- p53-responsive miR-194 inhibits thrombospondin-1 and promotes angiogenesis in colon cancers (Q34227513) (← links)
- Innovative treatments for pancreatic cancer. (Q34311382) (← links)
- Effect of oridonin-mediated hallmark changes on inflammatory pathways in human pancreatic cancer (BxPC-3) cells (Q34405150) (← links)
- Molecular pathogenesis of pancreatic ductal adenocarcinoma and clinical implications. (Q34446262) (← links)
- SEL1L a multifaceted protein playing a role in tumor progression. (Q34473389) (← links)
- The molecular targets for the diagnosis and treatment of pancreatic cancer (Q34494019) (← links)
- Cooperative assembly of Co-Smad4 MH1 with R-Smad1/3 MH1 on DNA: a molecular dynamics simulation study (Q34551844) (← links)
- Biology and management of pancreatic cancer (Q34649019) (← links)
- Molecular pathogenesis of pancreatic cancer (Q34684170) (← links)
- TGF-beta antagonists: why suppress a tumor suppressor? (Q34691800) (← links)
- Focus on pancreas cancer (Q34768641) (← links)
- Release of regulators of angiogenesis following Hypocrellin-A and -B photodynamic therapy of human brain tumor cells (Q34984986) (← links)
- Pancreatic cancer biology and genetics (Q35013204) (← links)
- Smad4 transcriptional pathways and angiogenesis (Q35079903) (← links)
- Expression of the type-1 repeats of thrombospondin-1 inhibits tumor growth through activation of transforming growth factor-beta (Q35102957) (← links)
- Gene Therapy for Pancreatic Cancer Targeting the Genomic Alterations of Tumor Suppressor Genes using Replication-selective Oncolytic Adenovirus (Q35110573) (← links)
- NF-kappaB in pancreatic cancer (Q35196538) (← links)
- A clinically relevant model of human pancreatic adenocarcinoma identifies patterns of metastasis associated with alterations of the TGF-beta/Smad4 signaling pathway (Q35196543) (← links)
- Genetics and prevention of pancreatic cancer (Q35641985) (← links)
- Pancreatic cancer stromal biology and therapy (Q35766799) (← links)
- Immunotherapy for pancreatic cancer - science driving clinical progress (Q36133140) (← links)
- miR-146a, an IL-1β responsive miRNA, induces vascular endothelial growth factor and chondrocyte apoptosis by targeting Smad4. (Q36245802) (← links)
- Essential role of endothelial Smad4 in vascular remodeling and integrity. (Q36315610) (← links)
- A deep boosting based approach for capturing the sequence binding preferences of RNA-binding proteins from high-throughput CLIP-seq data (Q36391211) (← links)
- Alteration of somatostatin receptor subtype 2 gene expression in pancreatic tumor angiogenesis (Q36474555) (← links)
- Determination of TGFbeta1 protein level in human primary breast cancers and its relationship with survival (Q36613581) (← links)
- Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. (Q36689648) (← links)
- Angiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomes. (Q36729407) (← links)
- Targeting signal transduction in pancreatic cancer treatment (Q36804444) (← links)